New Zealand markets closed

Syros Pharmaceuticals, Inc. (SYRS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.9500-0.0600 (-1.20%)
As of 03:39PM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
139,526
167,467
92,302
173,984
Other short-term investments
0
34,837
38,067
0
Total cash
139,526
202,304
130,369
173,984
Net receivables
-
-
0
7
Other current assets
5,454
7,394
3,237
2,242
Total current assets
144,980
211,392
136,585
178,557
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
27,117
37,215
37,141
36,857
Accumulated depreciation
-7,634
-12,555
-9,856
-7,216
Net property, plant and equipment
19,483
24,660
27,285
29,641
Equity and other investments
-
0
13,038
0
Other long-term assets
3,711
8,434
6,027
5,052
Total non-current assets
23,194
33,094
46,350
34,693
Total assets
168,174
244,486
182,935
213,250
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
6,667
-
-
-
Accounts payable
11,544
6,411
3,692
3,603
Accrued liabilities
9,153
9,437
9,280
5,369
Deferred revenues
0
4,330
10,181
12,209
Total current liabilities
36,681
30,778
31,508
28,624
Non-current liabilities
Long-term debt
34,556
40,649
40,257
39,551
Deferred revenues
-
-
0
9,877
Other long-term liabilities
61,747
24,472
3,029
19,711
Total non-current liabilities
114,831
85,972
66,209
94,073
Total liabilities
151,512
116,750
97,717
122,697
Stockholders' equity
Common stock
26
20
6
56
Retained earnings
-722,807
-558,233
-463,579
-377,021
Accumulated other comprehensive income
0
102
-79
0
Total stockholders' equity
16,662
127,736
85,218
90,553
Total liabilities and stockholders' equity
168,174
244,486
182,935
213,250